Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Limited impact of highly active antiretroviral therapy in thrombocytopenia.
J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):260-1. doi: 10.1097/00042560-200206010-00017.
J Acquir Immune Defic Syndr. 2002.
PMID: 12045691
No abstract available.
Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants.
Burbano X, Miguez-Burbano MJ, McCollister K, Zhang G, Rodriguez A, Ruiz P, Lecusay R, Shor-Posner G.
Burbano X, et al.
HIV Clin Trials. 2002 Nov-Dec;3(6):483-91. doi: 10.1310/A7LC-7C9V-EWKF-2Y0H.
HIV Clin Trials. 2002.
PMID: 12501132
Clinical Trial.
Item in Clipboard
Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy.
Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M.
Shor-Posner G, et al.
J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):169-73. doi: 10.1097/00042560-200202010-00010.
J Acquir Immune Defic Syndr. 2002.
PMID: 11832687
Item in Clipboard
Cite
Cite